These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23375978)

  • 1. Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes.
    Hopkins TG; Wood N
    Vaccine; 2013 Mar; 31(13):1673-9. PubMed ID: 23375978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
    Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
    Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of human papillomavirus immunization in the developing world.
    Kane MA; Serrano B; de Sanjosé S; Wittet S
    Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysis.
    Malagón T; Joumier V; Boily MC; Van de Velde N; Drolet M; Brisson M
    Vaccine; 2013 Mar; 31(13):1740-7. PubMed ID: 23384753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors impacting HPV vaccination: lessons for health care professionals.
    Hofstetter AM; Rosenthal SL
    Expert Rev Vaccines; 2014 Aug; 13(8):1013-26. PubMed ID: 24965128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark.
    Widgren K; Simonsen J; Valentiner-Branth P; Mølbak K
    Vaccine; 2011 Dec; 29(52):9663-7. PubMed ID: 22015392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of human papillomavirus vaccination in Nordic countries.
    Sander BB; Rebolj M; Valentiner-Branth P; Lynge E
    Vaccine; 2012 Feb; 30(8):1425-33. PubMed ID: 22154773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain.
    Limia A; Pachón I
    Euro Surveill; 2011 May; 16(21):. PubMed ID: 21632017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
    Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
    Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.
    Bosch FX; Tsu V; Vorsters A; Van Damme P; Kane MA
    Vaccine; 2012 Nov; 30 Suppl 5():F1-11. PubMed ID: 23199951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake.
    Donadiki EM; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; López de Andrés A; Velonakis EG
    Vaccine; 2012 Nov; 30(49):6967-70. PubMed ID: 23022147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions improving HPV vaccination uptake - Results from a national survey in Italy.
    Giambi C; Del Manso M; D'Ancona F; De Mei B; Giovannelli I; Cattaneo C; Possenti V; Declich S;
    Vaccine; 2015 May; 33(21):2425-31. PubMed ID: 25869895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
    Gertig DM; Brotherton JM; Saville M
    Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
    Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
    Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV; Laukkanen P; Koskela P; Kontula O; Lehtinen M; Garnett GP
    PLoS Med; 2006 May; 3(5):e138. PubMed ID: 16573364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.